The endocrinology of baldness

Hormones

Volumn 13, Issue 2, 2014, Pages 197-212

  Batrinos, Menelaos L ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

ACTH; Circadian rhythm; CLOCK system; Cortisol; Stress axis

Indexed keywords

ALBUMIN; ANDROGEN; ANDROGEN RECEPTOR; ANDROSTANOLONE; ANDROSTENEDIONE; DUTASTERIDE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTRONE; FINASTERIDE; FOLLITROPIN; GROWTH FACTOR; HEAT SHOCK PROTEIN; LUTEINIZING HORMONE; MINOXIDIL; PRASTERONE; PRASTERONE SULFATE; PROGESTERONE; PROLACTIN; PROSTATE SPECIFIC ANTIGEN; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN C; STEROID 5ALPHA REDUCTASE; STEROID RECEPTOR; TESTOSTERONE; TRANSFORMING GROWTH FACTOR BETA2; AR PROTEIN, HUMAN; ESTRADIOL DERIVATIVE; SEX HORMONE; STEROID 5ALPHA REDUCTASE INHIBITOR; TESTOSTERONE DERIVATIVE;

AGE DISTRIBUTION; ALOPECIA; AR GENE; ASIA; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CAUCASIAN; CELL CYCLE; CHINESE; CLINICAL FEATURE; COMORBIDITY; CONTACT DERMATITIS; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISTRESS SYNDROME; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG SAFETY; EJACULATION; ENDOCRINOLOGY; ERECTILE DYSFUNCTION; ETHNIC DIFFERENCE; FACIAL HIRSUTISM; FEMALE TYPE ALOPECIA; GENE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; HAIR; HAIR FOLLICLE; HAIR GROWTH; HAIR LOSS; HAIR TRANSPLANTATION; HEART INFARCTION; HIRSUTISM; HORMONE ACTION; HORMONE DETERMINATION; HUMAN; HYPOTENSION; INCIDENCE; LIBIDO; MALE TYPE ALOPECIA; MENOPAUSE; MORTALITY; PATHOPHYSIOLOGY; POPULATION RESEARCH; PROGNOSIS; PSYCHOLOGICAL ASPECT; REVIEW; SELF ESTEEM; SEX DIFFERENCE; SIDE EFFECT; SINGLE NUCLEOTIDE POLYMORPHISM; SUBSTITUTION THERAPY; TACHYCARDIA; UNSPECIFIED SIDE EFFECT; X CHROMOSOME; ANIMAL; BLOOD; COST OF ILLNESS; DRUG EFFECTS; FEMALE; GENETICS; MALE; METABOLISM; PHENOTYPE; PSYCHOLOGY; RISK FACTOR; TRANSPLANTATION;

3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE; 5-ALPHA REDUCTASE INHIBITORS; ALOPECIA; ANDROGENS; ANIMALS; COMORBIDITY; COST OF ILLNESS; ESTRADIOL CONGENERS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GONADAL STEROID HORMONES; HAIR FOLLICLE; HUMANS; INCIDENCE; MALE; PHENOTYPE; RECEPTORS, ANDROGEN; RISK FACTORS; SEX FACTORS; TESTOSTERONE CONGENERS;

EID: 84899659384     PISSN: 11093099     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401334     Document Type: Review

References (76)

1. Hamilton JB, 1960 Effect of castration in adolescent and young adult males upon further changes in the proportions of bare and hairy scalp. J Clin Endocrinol Metab 20: 1309-1318.
2. Cash TF, 1992 The psychological effects of androgenetic alopecia in men. J Am Acad Dermatol 26: 926-931.
3. Wells PA, Willmoth T, Russell RJ, 1995 Does fortune favour the bald? Psychological correlates of hair loss in males. Br J Psychol 86: 337-344.
4. Lee HJ, Ha SJ, Kim D, Kim HO, Kim JW, 2002 Perception of men with androegenetic alopecia by women and nonbalding men in Korea: How the nonbald regard the bald. Int J Dermatol 41: 867-869.
5. Budd D, Himmelberger D, Rhodes T, Cash TE, Girman CJ, 2000 The effects of hair loss in European men: a survey in four countries. Eur J Dermatology 10: 122-127.
6. Hamilton JB, 1951 Patterned loss of hair in man: Types and incidence. Ann NY Acad Sci 53: 708-728.
7. Norwood OT, 1975 Male pattern baldness: Classification and incidence. South Med J 68: 1359-1365.
8. Severi G, Sinclair R, Hopper JL, et al, 2003 Androgenetic alopecia in men aged 40-69 years: Prevalence and risk factors. Brit J Dermatology 149: 1207-1213.
9. Rhodes T, Girman CJ, Savin RC, 1998 Prevalence of male pattern hair loss in 18-49 year old men. Dermatol Surg 24: 1330-1332.
10. DeMuro-Mercon C, Rhodes T, Girman CJ, Vatten L, 2000 Male-pattern hair loss in Norwegian men: a communitybased study. Dermatology 200: 291-222.
11. Birch MP, Messenger AG, 2001 Genetic factors predispose to balding and non-balding in men. Eur J Dermatology 11: 309-314.
12. Gan DC, Sinclair RD, 2005 Prevalence of male and female hair loss in Maryborough. J Investig Dermatol Symp Proc 10: 184-189.
13. Tang PH, Chia HP, Cheong LL, Koh D, 2000 A community study of male androgenetic alopecia in Bishan, Singapore. Singapore Med J 41: 202-205.
14. Paik JH, Yoon JB, Sim WY, Kim BS, Kim NI, 2001 The prevalence and types of androgenetic alopecia in Korean men and women. Br J Dermatol 145: 95-99.
15. Xu F, Sheng YY, Mu ZL, et al, 2009 Prevalence and types of androgenetic alopecia in Shanghai, China: a community-based study. Br J Dermatol 160: 629-631.
16. Wang TL, Zhou C, Shen YW, 2010 Prevalence of androgenetic alopecia in China: A community-based study in six cities. Br J Dermatol 162: 843-847.
17. Pathomvanich D, Pongratananukul S, Thienthaworn P, Manoshai S, 2002 A random study of Asian male androegenetic alopecia in Bangkok, Thailand. Dermatol Surg 28: 804-807.
18. Lee WS, Lee HJ, 2012 Characteristics of androgenetic alopecia in Asian. Ann Dermatol 23: 243-252.
19. Courtois M, Loussouarn G, Hourseau C, Grollier JF, 1999 Hair cycle and alopecia. Skin Pharmacol 7: 84-89.
20. Messenger AG, 2011 Hair through the female life cycle. Br J Dermatol 165: Suppl 3: 1-6.
21. Randall VA, 2007 Hormonal regulation of hair follicles exhibits a biological paradox. Semin Cell Dev Biol 18: 274-289.
22. Chen CC, Chuong CM, 2012 Multi-layered environmental regulation on the homeostasis of stem cells: the saga of hair growth and alopecia. J Dermatol Sci 66: 3-11.
23. Randall VA, Ebling FJ, 1991 Seasonal changes in human hair growth. Br J Dermatol 124: 146-151.
24. Hibino T, Nishiyama T, 2004 Rolf of TGF-β2 in the human hair cycle. J Dermatol 35: 9-18.
25. Inui S, Itami S, 2011 Molecular basis of androgenetic alopecia: From androgen to paracrine mediators through dermal papilla. J Dermatol Science 61: 1-6.
26. Nafziger AN, Bowlin SJ, Jenkins PL, et al, 1998 Longitudinal changes in dehydroepiandrosterone concentrations in men and women. J Lab Clin Med 131: 316-323.
27. Kaufman JM, Vermeulen A, 1998 Androgens in male senescence. In: Nieschlag E, Behre HM (eds), Springer Verlag Berlin; pp,437-471.
28. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR, 2001 Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J Clin Endocrinol Metab 86: 724-731.
29. Zouboulis CC, Degitz K, 2004 Androgen action on human skin-from basic research to clinical significance. Exp Dermatol 13: Suppl 4: 5-10.
30. Alsantali A, Shapiro J, 2009 Androgens and hair loss. Curr Opin Endocrinol Diabetes Obes 16: 246-253.
31. Sawaya ME, Price VH, 1997 Different levels of 5alphareductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia. J Invest Dermatol 109: 296-300.
32. Quigley CA, 1998 The androgen receptor: Physiology and pathophysiology. In: Nieschlag E, Behre HM (eds), Testosterone Action Deficiency Substitution, Springer Verlag Berlin; pp, 83-106.
33. Sinclair R, Greenland KJ, van Egmond V, 2007 Men with Kennedy disease have a reduced risk of androgenetic alopecia. Br J Dermatol 157: 290-294.
34. Hibberts NA, Howell AE, Randall VA, 1998 Balding hair follicle dermal papilla cells contain higher levels of androgen receptors than those from non-balding scalp. J Endocrinol 156: 59-65.
35. McKenna NJ, Lanz RB, O' Malley BW, 1999 Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev 20: 321-344.
36. Heinlein CA, Chang C, 2002 Androgen receptor (AR) coregulators: An overview. Endocrine Reviews 23: 175-200.
37. Thakur MK, Paramanik V, 2004 Role of steroid hormone coregulators in health and disease. Horm Res 71: 194-200.
38. Zhuo FL, Xu W, Wang L, 2011 Androgen receptor gene polymorphisms and risk for androgenetic alopecia: a meta-analysis. Clin Exper Dermatol 37: 104-111.
39. Prodi DA, Pirastu N, Maninchedda G, 2008 EDA2R is associated with androgenetic alopecia. J Invest Dermatology 128: 2268-2270.
40. Hillmer AM, Flaquer A, Hanneken S, 2008 Genome-wide scan and fine-mapping linkage study of androgenetic alopecia reveals a locus on chromosome 3q26. Amer J Human Genetics 82: 737-743.
41. Richards JB, Yuan X, Geller F, 2008 Male-pattern baldness susceptibility locus at 20p11. Nat Genet 40: 1282-1284.
42. Cobb JE, Zaloumis SG, Scurrah KJ, Harrap SB, Ellis JA, 2010 Evidence for two independent functional variants for androgenetic alopecia around the androgen receptor gene. Exp Dermatol 19:1026-1028.
43. Hawk E, Breslow RA, Graubard B, 2000 Male pattern baldness and clinical prostate cancer in the epidemiologic follow-up of the first National Health and Nutrition Examination Survey. Cancer Epidemiol Biom 9: 523-527.
44. Giles GC, Severi G, Sinclair R, 2002 Androgenetic alopecia and prostate cancer: Findings from an Australian case-control study. Cancer Epidemiol Biomarkers Prev 11: 549-556.
45. Hayes VM, Severi G, Padilla EJD, 2006 5a-reductase type 2 variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia. Int J Cancer 120: 776-780.
46. Hsieh CC, Thanos A, Mitropoulos D, et al, 1999 Risk factors for prostate cancer: a case-control study in Greece. Int J Cancer 80: 699-703.
47. Faydaci G, Bilal E, Necmettin P, 2008 Baldness, benign prostate hyperplasia, prostate cancer and androgen levels. The Aging Male 11: 189-192.
48. Herrera CR, D' Agostino RB, 1995 Baldness and coronary heart disease rates in men from the Framingham study. Amer J Epidemiol 142: 828-833.
49. Lesko SM, Rosenberg L, Shapiro S, 1993 A case-control study of baldness in relation to myocardial infarction in men. JAMA 269: 998-1003.
50. Ford ES, Freedman DS, Byers T, 1996 Baldness and ischemic heart disease in a national sample of men. Am J Epidemiol 143: 651-657.
51. Lotufo PA, Chae CU, Ajani UA 2000 Male pattern baldness and coronary heart disease: The physicians' Health Study. Arch Intern Med 160: 165-171.
52. Rebora A, 2001 Baldness and coronary artery disease. Arch Dermatol 137: 943-947.
53. Cutersohn T, Scheidegger EP, 2005 Is baldness bad for the heart? Dermatology 74: 1399-1406.
54. Shahar E, Heiss G, Rosamond WD, Szklo M, 2008 Baldness and myocardial infarction in men. The atherosclerosis risk in communities study. Am J Epidemiol 167: 676-683.
55. Arias-Santiago S, Gutierrez-Salmeron MT, Castellote-Caballero L, 2010 Androgenetic alopecia and cardiovascular risk factors in men and women: A comparative study. J Am Acad Dermatol 63: 420-429.
56. Birch MP, Messenger JF, Messenger AG, 2001 Hair density, hair diameter and the prevalence of female pattern hair loss. Br J Dermatol 144: 297-304.
57. Ludwig E, 1977 Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol 97: 247-254.
58. Norwood OT, 2001 Incidence of female androgenetic alopecia (female pattern alopecia). Dermatol Surg 27: 53054.
59. Birch MP, Messenger JF, Messenger AG, 2001 Hair density, hair diameter and the prevalence of female pattern hair loss. Br J Dermatol 144: 297-304.
60. Su LH, Li-Sheng C, Hsiu-His C, 2012 Factors associated with female pattern hair loss and its prevalence in Taiwanese women: A community-based survey. J Am Acad Dermatol 69: e69-77.
61. Yip L, Rufaut R, Sinclair R, 2011 Role of genetics and sex steroid hormones in male androgenetic alopecia and female pattern hair loss: An update of what we now know. Austr Dermatol 52: 81-88.
62. El-Samahy MH, Shaheen MA, Saddik DE, 2009 Evaluation of androgen receptor gene as a candidate gene in female androgenetic alopecia. Int J Dermatol 48: 584-587.
63. Redler S, Tazi-Ahnini R, Drichel D, 2012 Selected variants of the steroid-5-alpha-reductase isoforms SRD5A1 and SRD5A2 and the sex steroid hormone receptors ESR1, ESR2 and PGR: No association with female pattern hair loss identified. Exp Dermatol 21: 390-393.
64. Yip L, Zaloumis S, Irwin D, 2009 Gene-wide association study between the aromatase gene (CYP19A1) and female pattern hair loss. Brit J Dermatol 161: 289-294.
65. Longcope C, 1986 Adrenal and gonadal androgen secretion in normal females. Clin Endocrinol Metab 15: 213-228.
66. Burger HG, Dudley EC, Cui J, 2006 A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition. J Clin Endocrinol Metab 85: 2832-2838.
67. Zouboulis CC, Chen WC, Thornton MJ, Rosenfield R, 2007 Sexual hormones in human skin. Horm Metab Res 39: 85-95.
68. Orme S, Cullen DE, Messenger AG, 1999 Diffuse hair loss: are androgens necessary? Br J Dermatol 141: 521-523.
69. Batrinos ML, 2012 The aging of the endocrine hypothalamus and its dependent endocrine glands. Hormones (Athens) 11: 241-253.
70. Mirmirani P, 2011 Hormonal changes in menopause: do they contribute to a "midlife hair crisis" in women? Br J Dermatol 165: Suppl 3: 7-11.
71. Blumeyer A, Tosti A, Messenger A, Reygagne P, 2011 Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men. J Dtsch Dermatol Ges 9: Suppl 6: 1-57.
72. Miteva M, Tosti A, 2012 Treatment options for alopecia: An update, looking to the future. Expert Opin Pharmacother 13: 1271-1281.
73. Blume-Peytavi U, Atkins S, Gieler U, Grimalt R, 2012 Skin academy: hair, skin, hormones and menopause-current status / knowledge on the management of hair disorders in menopausal women. Eur J Dermatol 22: 310-318.
74. Otberg N, Finner AM, Shapiro J, 2007 Androgenetic alopecia. Endrocrinol Metab Clin N Am 36: 379-398.
75. McElwee KJ, Shapiro J, 2012 Promising therapies for treating and/or preventing androgenic alopecia. Skin Therapy Lett 17: 1-4.
76. Rangwala S, Rashid RM, 2012 Alopecia: a review of laser and light therapies. Dermatol Online J 18: 3.